Vascular Solutions, Inc., a prominent player in the medical device industry, is headquartered in the United States and operates extensively across North America and Europe. Founded in 1997, the company has established itself as a leader in developing innovative solutions for vascular access and intervention. Vascular Solutions is renowned for its core products, including the patented Vascular Closure Devices and a range of catheter-based technologies, which are distinguished by their reliability and ease of use. The company has achieved significant milestones, including numerous FDA approvals, solidifying its market position as a trusted provider in the vascular sector. With a commitment to advancing patient care, Vascular Solutions continues to push the boundaries of medical technology, making it a key player in the evolving landscape of vascular health.
How does Vascular Solutions, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Vascular Solutions, Inc.'s score of 72 is higher than 84% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Vascular Solutions, Inc., headquartered in the US, currently does not report specific carbon emissions data, as indicated by the absence of emissions figures. The company is a current subsidiary of Teleflex Incorporated, which may influence its climate commitments and reporting practices. While Vascular Solutions, Inc. does not have its own documented reduction targets, it is important to note that any climate initiatives or targets may be inherited from its parent company, Teleflex Incorporated. This includes potential commitments to the Science Based Targets initiative (SBTi) and other sustainability frameworks, although specific details on these initiatives are not provided. As a subsidiary, Vascular Solutions, Inc. may align its environmental strategies with those of Teleflex, which could include broader industry standards and practices aimed at reducing carbon footprints and enhancing sustainability. However, without specific emissions data or reduction targets, the company's individual climate commitments remain unclear.
Access structured emissions data, company-specific emission factors, and source documents
| 2019 | 2023 | 2024 | |
|---|---|---|---|
| Scope 1 | 15,877,000 | 00,000,000 | 00,000,000 | 
| Scope 2 | 70,751,000 | 00,000,000 | 00,000,000 | 
| Scope 3 | 391,390,000 | 000,000,000 | - | 
Vascular Solutions, Inc.'s Scope 3 emissions, which decreased by 5% last year and decreased by approximately 5% since 2019, demonstrating supply chain emissions tracking. The vast majority of their carbon footprint comes from suppliers and value chain emissions, representing the vast majority of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 78% of Scope 3 emissions.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Vascular Solutions, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.